Fenwick & West has advised Star Therapeutics on the transaction, while Goodwin Procter has advised Incyte. Star Therapeutics and Incyte have announced a definitive agreement in...
Incyte to Acquire Vega Therapeutics from Star Therapeutics for Up to $2 Billion
Incyte’s AI-focused Research Collaboration with Genesis Therapeutics
Baker McKenzie advised Incyte on the deal. Global biopharmaceutical company, Incyte (Nasdaq: INCY), has announced a strategic collaboration agreement with Genesis Therapeutics for the use of...
Incyte’s Acquisition of Villaris Therapeutics
Sidley represented Incyte on the deal. Incyte (NASDAQ:INCY) announced its agreement to acquire Villaris Therapeutics, a biopharmaceutical company focused on the development of novel antibody therapeutics. The...